News for Healthier Living

Wesper Revolutionizes GLP-1 Sleep Apnea Screening and Enables Personalized Treatment

Wesper, a leader in advanced home sleep apnea testing (HSAT), is transforming how obesity and sleep apnea are managed by integrating groundbreaking biometric sleep data with metabolic health innovations. Following the FDA approval of GLP-1 receptor agonists for sleep apnea treatment, Wesper is working with hospitals and physicians to bridge the gap between obesity, diabetes, GLP-1 medications, and sleep apnea.

February 11, 2025


February 12 2025

February 11 2025

February 10 2025

February 9 2025

February 8 2025

February 7 2025

February 6 2025

February 5 2025

February 4 2025

February 3 2025

February 2 2025

February 1 2025

January 31 2025

January 30 2025

January 29 2025